Receptor antagonists targeting transmembrane domains

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.5, Iss.2, 2000-07, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rational Targeting of the Urokinase Receptor (uPAR): Development of Antagonists and Non-Invasive Imaging Probes

Current Drug Targets, Vol. 12, Iss. 12, 2011-01 ,pp. : 1711-1728

Bentham Science Publishers

Access to resources Recommend Favorite

Urotensin-II Receptor Antagonists

Current Medicinal Chemistry, Vol. 13, Iss. 3, 2006-02 ,pp. : 267-275

Bentham Science Publishers

Access to resources Recommend Favorite

Muscarinic Receptor Antagonists

By Watson N. Eglen R.M.

Pulmonary Pharmacology & Therapeutics, Vol. 12, Iss. 2, 1999-04 ,pp. : 115-118

Academic Press

Access to resources Recommend Favorite

Angiotensin II receptor antagonists -

By Burnier M. Brunner H.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 5, 1997-05 ,pp. : 489-500

Informa Healthcare

Access to resources Recommend Favorite

Progesterone receptor agonists and antagonists

By Allan G. Macielag M.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 7, 1999-07 ,pp. : 955-962

Informa Healthcare

Access to resources Recommend Favorite